1. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer
   Sung Uk Bae et al, 2018, Cancer Imaging CrossRef
2. Comment on “Is the Routine Dissection of Lateral Lymph Nodes Really Necessary After Mesorectal Excision for Clinical Stage II/III Lower Rectal Cancer?”
   Roberto Cirocchi et al, 2019, Annals of Surgery CrossRef
3. Update on indications for lateral lymph node dissection in the management of lower rectal cancer
   Derek Tak Lit Fung et al, 2020, ANZ Journal of Surgery CrossRef
4. Feasibility of Assessing Prognostic Nutrition Index in Patients With Rectal Cancer Who Receive Preoperative Chemoradiotherapy
   Yoshinaga Okugawa et al, 2018, Journal of Parenteral and Enteral Nutrition CrossRef
5. Effect and Safety of Radiation Therapy Boost to Extramesorectal Lymph Nodes in Rectal Cancer
   Haihui Chen et al, 2020, Practical Radiation Oncology CrossRef
6. Management of synchronous lateral pelvic nodal metastasis in rectal cancer in the era of neoadjuvant chemoradiation: A systemic review
   Jolene Si Min Wong et al, 2020, World Journal of Gastrointestinal Surgery CrossRef
7. Significance, diagnosis and treatment of lateral lymph nodes in rectal cancer: A systematic review
   Stephanie Gulevski et al, 2019, International Journal of Surgery Open CrossRef
8. Prognostic Potential of Lymphocyte–C-Reactive Protein Ratio in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy
   Yoshinaga Okugawa et al, 2021, Journal of Gastrointestinal Surgery CrossRef
9. The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes
   Elisa Meldolesi et al, 2022, Cancers CrossRef
10. Neoadjuvant chemoradiotherapy followed by lateral pelvic lymph node dissection for rectal cancer patients: A retrospective study of its safety and indications
    Sicheng Zhou et al, 2021, Journal of Surgical Oncology CrossRef
11. The expression of carcinoembryonic antigen mRNA in the lavage of the dissected area of the lateral lymph nodes influences the lateral recurrence of lower rectal cancer
    Korehito Takasu et al, 2022, Surgery Today CrossRef
12. Feasibility, Indications, and Prognostic Significance of Selective Lateral Pelvic Lymph Node Dissection After Preoperative Chemoradiotherapy in Middle/Low Rectal Cancer: Results of a Multicenter Lateral Node Study in China
    Sicheng Zhou et al, 2024, Diseases of the Colon & Rectum CrossRef
13. Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis
    Sicheng Zhou et al, 2021, BMC Surgery CrossRef
14. Establishing and validating predictive nomograms for lateral pelvic lymph node metastasis in patients with rectal cancer based on radiologic factors and clinicopathologic characteristics
    Sicheng Zhou et al, 2023, European Journal of Surgical Oncology CrossRef
15. Optimization of therapeutic strategies for selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in patients with rectal cancer with clinical suspected lateral lymph node metastasis
    Yuan Liu et al, 2023, Frontiers in Oncology CrossRef
16. Evaluating predictive factors for determining the presence of lateral pelvic node metastasis in rectal cancer patients following neoadjuvant chemoradiotherapy
    P. Wang et al, 2019, Colorectal Disease CrossRef